What’s News in Markets: CarMax Woes, Intel Soars, Tylenol Pressure

27 Sep 2025 · 5 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

WSJ Your Money Briefing: Episode Summary

Episode Title

What’s News in Markets: CarMax Woes, Intel Soars, Tylenol Pressure Host: Jack Pitcher Date: September 27, 2025 Podcast Description: A personal-finance and career checklist that helps listeners make informed decisions about managing their money.

Episode Overview In this episode, host Jack Pitcher discusses significant developments in the stock market for the week, including major earnings reports and stock movements. The focus is on three key players: CarMax, Intel, and Kenvue (the maker of Tylenol).

Key Topics Discussed

  1. Market Performance Overview
  2. Record Openings: The week started strong with all three major stock indexes reaching record highs on Monday.
  3. Economic Indicators:
  4. Second Quarter GDP Growth: Final estimate increased to 3.8% from a prior estimate of 3.3%.
  5. Jobless Claims: A decline in new unemployment claims was reported.
  6. Durable Goods Orders: Showed a rebound, indicating economic strength.
  1. Intel's Surge
  2. Stock Performance: Intel's stock rose 20% for the week and 46% for the month, marking its best performance since 1987.
  3. Key Developments:
  4. Partnership discussions with Apple and Taiwan Semiconductor Manufacturing.
  5. NVIDIA's $5 billion investment in Intel.
  6. Federal government’s 10% stake in Intel, boosting investor confidence.
  1. CarMax's Disappointing Earnings
  2. Earnings Report: CarMax reported significantly lower than expected earnings, causing a 20% drop in stock price to a five-year low, and a total drop of 23% for the week.
  3. Sales Performance: A sharp decline in used car sales attributed to changes in market demand and economic conditions.
  4. Industry Implications: Raises concerns about the overall health of the auto industry amidst a tough economic climate.
  1. Kenvue's (Tylenol) Challenges
  2. Market Impact: Kenvue's stock fell over 10% this week and is down 23% for the year.
  3. Legal Concerns: Following a controversial statement by President Trump regarding the safety of Tylenol for pregnant women, which has potential implications for litigation.
  4. Historical Context: Kenvue has previously defended itself against lawsuits regarding autism links, with a federal judge ruling in its favor in 2023.

Summary of Market Trends

  • Overall Market Performance:
  • S&P 500: Down 0.3% for the week.
  • Dow Jones: Down 0.1%.
  • Nasdaq: Down 0.7%.
  • Investor Sentiment: Despite strong economic indicators, skepticism remains due to high valuations for tech stocks and financial stress among lower-income consumers.

Conclusion The episode concludes with a recap of the week's market movements and a reminder of the ongoing developments affecting these companies. The host encourages listeners to stay informed as the economic landscape continues to evolve.

---

Note: Ensure to subscribe to the WSJ's free Markets A.M. newsletter for ongoing financial news updates.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Isn't home where we all want to be? Reba here for Realtor.com. The pros number one most trusted app. Finding a home is like dating. You're searching for the one. With over 500 ,000 new listings every month, you can find the one today. Download the Realtor.com app because you're nearly home. Make it real with Realtor.com. Pros, number one most trusted app based on August 2025 proprietary survey. Over 500 ,000 new listings every month based on average new for sale and rental listings, July 2024 to June 2025. Hey listeners, your money briefing is on a break, but we'll be back with more personal finance information for you in the future.

0:36Until then, here's the news moving markets this week. Hey, listeners. It's Saturday, September 27th. I'm Jack Pitcher for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them. Let's get to it. Stocks opened hot this week when all three major indexes set records on Monday. But markets lost steam as the week went on, and not for any lack of good economic news. The government's final estimate of second quarter GDP growth came in at a strong 3.8%, compared with a prior estimate of 3.3%. Meanwhile, weekly jobless claims showed a drop in the number of Americans who newly filed for unemployment, and monthly durable goods orders bounced back.

1:23All three data points back up the idea that the AI-powered American economy is just fine and in fact is set to heat back up. That's the very view that's pushed stocks to record after record in recent weeks. So what gives? Well, skeptics point out the historically expensive valuations for top tech stocks and signs of stress among lower income consumers. But for now, markets aren't all that phased, finishing Friday just under records. For the week, the S &P 500 dropped 0.3%, while the Dow was 0.1 % lower. The tech-heavy Nasdaq fell 0.7%.

2:07The good times keep rolling for Intel. A Wall Street Journal report Thursday that chipmaker has approached both Apple and Taiwan's semiconductor manufacturing about partnerships sent the stock soaring. That came after last week's news that NVIDIA will invest$5 billion in Intel as part of a new partnership. Intel has notched a string of victories since the U.S. government agreed to take a 10 % stake in the long-suffering chipmaker, and so patient investors have been rewarded. Since hitting decade-plus lows as recently as July, Intel's stock has almost doubled. Shares rose 20 % this week, and they're up 46 % so far this month, on pace for their best performance since 1987.

2:59Of course, not everything is soaring. CarMax, the biggest seller of used cars in the U.S., posted dismal earnings on Thursday. That sent its stock tanking. Used car sales fell sharply in the second quarter, crashing back to earth following a first quarter spike. That was fueled by higher demand due to uncertainty about tariffs. Sales and profits came in far below analyst estimates, and CarMax's CEO told analysts the consumer has been, quote, distressed for a little while. The earnings were the latest point of concern for an auto industry that's had a tough 2025, and they're further evidence of a slowdown in the so-called real economy that isn't benefiting from huge spending on AI.

3:42CarMax shares fell 20 % Thursday to a five-year low, and they lost 23 % for the week. The maker of Tylenol, Kenview, is continuing to struggle after an explosive White House news conference on Monday. President Trump warned the public that pregnant women should not take Tylenol due to its alleged links to autism. It was an event that stunned many of the nation's doctors and public health experts, some of whom dispute that there are any links. Kenview is now preparing for an explosion of litigation over its popular pain reliever. The drugmaker has successfully fended off past lawsuits, including most notably in 2023, when a federal judge ruled there wasn't sufficient evidence that Tylenol caused autism and dismissed lawsuits against Kenview.

4:28Shares of the company fell more than 10 % this week and are down 23 % for the year.

4:37And now you know what's news in markets this week. Today's show is produced by Rodney Davis with Deputy Editor Chris Zinsley. I'm Jack Pitcher. Have a great weekend and see you next Saturday.

From the publisher

Why did CarMax’s earnings spook investors? And how has Intel stock gained 46% this month? Plus, what’s driving a sharp selloff in Kenvue shares? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them.

Sign up for the WSJ's free Markets A.M. newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

More from WSJ Your Money Briefing

All 57 episodes
What’s News in Markets: CarMax Woes, Intel Soars, Tylenol PressureWSJ Your Money Briefing · 5 min
Listen in VO